Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2023 Results
Legend Biotech Corporation (LEGN) will host a conference call to review fourth-quarter and full-year 2023 results. Executive members will discuss the company's performance during the call.
02/13/2024 - 08:00 AM
SOMERSET, N.J. --(BUSINESS WIRE)--
Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing, and commercializing novel therapies to treat life-threatening diseases, will host a conference call for investors at 8:00 am ET on Monday, March 11, 2024, to review fourth-quarter and full-year 2023 results.
During the webcast and conference call, executive members will provide an overview of Legend Biotech’s performance for the quarter and the fiscal year.
Investors and other interested parties may join the live audio webcast of the call via this weblink .
A replay version of the webcast and earnings news release will be available through the Investor Relations section of Legend Biotech’s website under the Events and Presentation section approximately two hours after the call concludes.
ABOUT LEGEND BIOTECH
Legend Biotech is a global biotechnology company dedicated to treating, and one day curing, life-threatening diseases. Headquartered in Somerset, New Jersey , we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell (gd T) and natural killer (NK) cell-based immunotherapy. From our three R&D sites around the world, we apply these innovative technologies to pursue the discovery of cutting-edge therapeutics for patients worldwide.
Learn more at www.legendbiotech.com and follow us on X (formerly Twitter) and LinkedIn .
View source version on businesswire.com: https://www.businesswire.com/news/home/20240213850036/en/
INVESTOR:
Jessie Yeung
jessie.yeung@legendbiotech.com
PRESS:
media@legendbiotech.com
Source: Legend Biotech Corporation
When will Legend Biotech host a conference call to review fourth-quarter and full-year 2023 results?
Legend Biotech will host a conference call at 8:00 am ET on Monday, March 11, 2024.
Where can investors join the live audio webcast of the call?
Investors can join the live audio webcast of the call via the weblink provided by Legend Biotech.
Where can interested parties find the replay version of the webcast and earnings news release?
Interested parties can find the replay version of the webcast and earnings news release in the Investor Relations section of Legend Biotech's website under the Events and Presentation section.
LEGN Rankings
#704 Ranked by Stock Gains
LEGN Stock Data
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Tags
Commercial Services, Miscellaneous Commercial Services, Health Technology, Pharmaceuticals: Major, Manufacturing, Pharmaceutical Preparation Manufacturing
Country
United States
City
Somerset
About LEGN
legend biotech corporation is an emerging company focusing on the development of the best-in-class immunotherapy technology for cancer cure. teamed up with outstanding immunologists and molecular biologists, legend has generated a strong pipeline of chimeric antigen receptor(car) product candidates to treat a wide variety of liquid and solid tumors. our ambition to succeed in the cars field has been substantially fulfilled by the latest clinical trial results that we have achieved a great clinical success in treating multiple myeloma, a previously incurable blood cancer. by applying one of our proprietary car-t technology, we have reached a promising result in the clinical research for the enrolled patient group bearing refractory and relapsed multiple myeloma. legend biotech corporation is founded on the vision that the previous incurable previousincurable cancer will be safely and effectively treated with fine-tuning products generated on our innovative technology platform. we take o
